Publication:
Treatment of Acute Hepatitis C Virus Infection with Interferon-? 2b and Ribavirin: Case Report and Review of the Literature

dc.contributor.authorLeblebicioglu H.
dc.contributor.authorBayirli D.
dc.contributor.authorEsen S.
dc.contributor.authorSunbul M.
dc.contributor.authorEroglu C.
dc.date.accessioned2020-06-21T09:14:52Z
dc.date.available2020-06-21T09:14:52Z
dc.date.issued2002
dc.departmentOMÜen_US
dc.department-tempLeblebicioglu, H., Dept. Infect. Dis./Clin. Microbiol., Ondokuz Mayis Univ. Medical School, Samsun, Turkey -- Bayirli, D., Dept. Infect. Dis./Clin. Microbiol., Ondokuz Mayis Univ. Medical School, Samsun, Turkey -- Esen, S., Dept. Infect. Dis./Clin. Microbiol., Ondokuz Mayis Univ. Medical School, Samsun, Turkey -- Sunbul, M., Dept. Infect. Dis./Clin. Microbiol., Ondokuz Mayis Univ. Medical School, Samsun, Turkey -- Eroglu, C., Dept. Infect. Dis./Clin. Microbiol., Ondokuz Mayis Univ. Medical School, Samsun, Turkey --en_US
dc.description.abstractHepatitis C virus (HCV) infection becomes chronic in about 85 % of individuals as demonstrated by the persistence of HCV. It is necesseray to treat acute hepatitis C infection. Interferon-?is generally used for the treatment of acute HCV infection. Case presentation: A 55-year-old woman with a history of fatique and icter was diagnosed as acute hepatitis C virus infection. She was treated with interferon-? 2b 3 million unite sc three times in a week and ribavirin 1000 mg daily for 6 months. Within 2 weeks of therapy, the alanine aminotransferase (ALT) had became normal. At the end of the 3 months of therapy, HCV RNA was negative and remained negative 6 months after the end of interferon treatment (sustained response). Conclusion: This report suggests that interferon-? 2b and ribavirin may have a role in treatment of acute hepatitis C virus infection. © 2002 Leblebicioglu et al; licensee BioMed Central Ltd.en_US
dc.identifier.doi10.1186/1476-0711-1-3
dc.identifier.issn1476-0711
dc.identifier.pmid12437778
dc.identifier.urihttps://doi.org/10.1186/1476-0711-1-3
dc.identifier.urihttps://hdl.handle.net/20.500.12712/2553
dc.identifier.volume1en_US
dc.language.isoenen_US
dc.relation.journalAnnals of Clinical Microbiology and Antimicrobialsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleTreatment of Acute Hepatitis C Virus Infection with Interferon-? 2b and Ribavirin: Case Report and Review of the Literatureen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files